Disclaimer :

The Competition DG makes the information provided by the notifying parties in section 1.2 of Form CO available to the public in order to increase transparency. This information has been prepared by the notifying parties under their sole responsibility, and its content in no way prejudges the view the Commission may take of the planned operation. Nor can the Commission be held responsible for any incorrect or misleading information contained therein.

SECTION 1.2

Description of the concentration

On 7 January 2016, the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation by which Dentsply International Inc. (“Dentsply”) acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Sirona Dental Systems, Inc. (“Sirona”) under an Agreement and Plan of Merger dated 15 September 2015. The business activities of the parties are:

a. Dentsply is a designer, developer, manufacturer and marketer of a broad range of consumable dental products for the professional dental market. Dentsply also manufactures and markets other consumable medical device products. Dentsply is incorporated in Delaware and its common stock is traded on NASDAQ under the symbol “XRAY”. Dentsply’s worldwide headquarters and executive offices are located in York, Pennsylvania.

b. Sirona is a global manufacturer of technologically-advanced dental equipment and is focused on developing, manufacturing, and marketing innovative solutions for dentists. Sirona is incorporated in Delaware and its common stock is traded on NASDAQ under the symbol “SIRO”. Sirona’s headquarters are in Long Island City, New York and its largest facility is located in Bensheim, Germany.

Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË

Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.